OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An exploration of how broadly neutralizing antibodies might induce HIV remission: the ‘vaccinal’ effect
Timothy Tipoe, Sarah Fidler, John Frater
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 3, pp. 162-170
Closed Access | Times Cited: 10
Timothy Tipoe, Sarah Fidler, John Frater
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 3, pp. 162-170
Closed Access | Times Cited: 10
Showing 10 citing articles:
New developments in antiretroviral therapy strategies to improve clinical management of neonates and young infants with HIV
Lisa Frigati, Shaun Barnabas, Adrie Bekker
Current Opinion in HIV and AIDS (2025)
Closed Access
Lisa Frigati, Shaun Barnabas, Adrie Bekker
Current Opinion in HIV and AIDS (2025)
Closed Access
The impact of analytical treatment interruptions and trial interventions on time to viral re‐suppression in people living with HIV restarting ART in cure‐related clinical studies: a systematic review and meta‐analysis
Ming Lee, Miles Eason, Antonella Castagna, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. 8
Open Access | Times Cited: 2
Ming Lee, Miles Eason, Antonella Castagna, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. 8
Open Access | Times Cited: 2
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure
Jairo A. Fonseca, Alexis C. King, Ann Chahroudi
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 1, pp. 11-29
Open Access | Times Cited: 1
Jairo A. Fonseca, Alexis C. King, Ann Chahroudi
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 1, pp. 11-29
Open Access | Times Cited: 1
Preventing perinatal HIV acquisition; current gaps and future perspectives
Beatrice Cockbain, Sarah Fidler, Hermione Lyall
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 6, pp. 293-304
Open Access | Times Cited: 1
Beatrice Cockbain, Sarah Fidler, Hermione Lyall
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 6, pp. 293-304
Open Access | Times Cited: 1
Post-intervention control in HIV immunotherapy trials
Demi Sandel, Rachel L. Rutishauser, Michael J. Peluso
Current Opinion in HIV and AIDS (2024) Vol. 20, Iss. 1, pp. 70-79
Closed Access | Times Cited: 1
Demi Sandel, Rachel L. Rutishauser, Michael J. Peluso
Current Opinion in HIV and AIDS (2024) Vol. 20, Iss. 1, pp. 70-79
Closed Access | Times Cited: 1
Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination
Corné P.G. Nel, John Frater
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Corné P.G. Nel, John Frater
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality
Laura Waters, Rosa de Miguel Buckley, Sébastien Poulin, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 6, pp. 1136-1141
Closed Access | Times Cited: 8
Laura Waters, Rosa de Miguel Buckley, Sébastien Poulin, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 6, pp. 1136-1141
Closed Access | Times Cited: 8
Broadly neutralizing antibodies: “The next thing” to treat children with HIV?
Maud Mavigner, Ann Chahroudi
Science Translational Medicine (2023) Vol. 15, Iss. 703
Closed Access | Times Cited: 4
Maud Mavigner, Ann Chahroudi
Science Translational Medicine (2023) Vol. 15, Iss. 703
Closed Access | Times Cited: 4
Polyfunctionality of broadly neutralizing HIV-1 antibodies
Lou-Léna Vrignaud, Olivier Schwartz, Timothée Bruel
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 178-183
Open Access | Times Cited: 2
Lou-Léna Vrignaud, Olivier Schwartz, Timothée Bruel
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 178-183
Open Access | Times Cited: 2
Investigational drugs for HIV: trends, opportunities and key players
Ronald J. Overmars, Zoë Krullaars, Thibault Mésplède
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 2, pp. 127-139
Closed Access | Times Cited: 1
Ronald J. Overmars, Zoë Krullaars, Thibault Mésplède
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 2, pp. 127-139
Closed Access | Times Cited: 1
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
Jord C. Stam, Steven de Maat, Dorien de Jong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Jord C. Stam, Steven de Maat, Dorien de Jong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
